X-Ray Structure of Thrombin Bound to a Heterobifunctional Aptamer-Drug Conjugate Reveals the Mechanistic Basis for a Novel Tethered Inhibition Strategy
Publication
, Conference
Kumar, S; Yu, H; Sullenger, BA; Krishnaswamy, S
Published in: Blood
November 15, 2022
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 15, 2022
Volume
140
Issue
Supplement 1
Start / End Page
1668 / 1669
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kumar, S., Yu, H., Sullenger, B. A., & Krishnaswamy, S. (2022). X-Ray Structure of Thrombin Bound to a Heterobifunctional Aptamer-Drug Conjugate Reveals the Mechanistic Basis for a Novel Tethered Inhibition Strategy. In Blood (Vol. 140, pp. 1668–1669). American Society of Hematology. https://doi.org/10.1182/blood-2022-163410
Kumar, Shekhar, Haixiang Yu, Bruce A. Sullenger, and Sriram Krishnaswamy. “X-Ray Structure of Thrombin Bound to a Heterobifunctional Aptamer-Drug Conjugate Reveals the Mechanistic Basis for a Novel Tethered Inhibition Strategy.” In Blood, 140:1668–69. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-163410.
Kumar S, Yu H, Sullenger BA, Krishnaswamy S. X-Ray Structure of Thrombin Bound to a Heterobifunctional Aptamer-Drug Conjugate Reveals the Mechanistic Basis for a Novel Tethered Inhibition Strategy. In: Blood. American Society of Hematology; 2022. p. 1668–9.
Kumar, Shekhar, et al. “X-Ray Structure of Thrombin Bound to a Heterobifunctional Aptamer-Drug Conjugate Reveals the Mechanistic Basis for a Novel Tethered Inhibition Strategy.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 1668–69. Crossref, doi:10.1182/blood-2022-163410.
Kumar S, Yu H, Sullenger BA, Krishnaswamy S. X-Ray Structure of Thrombin Bound to a Heterobifunctional Aptamer-Drug Conjugate Reveals the Mechanistic Basis for a Novel Tethered Inhibition Strategy. Blood. American Society of Hematology; 2022. p. 1668–1669.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 15, 2022
Volume
140
Issue
Supplement 1
Start / End Page
1668 / 1669
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology